Your browser doesn't support javascript.
loading
Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease.
Shcherbinin, Sergey; Morris, Amanda; Higgins, Ixavier A; Tunali, Ilke; Lu, Ming; Deveau, Carmen; Southekal, Sudeepti; Kotari, Vikas; Evans, Cynthia D; Arora, Anupa K; Collins, Emily C; Pontecorvo, Michael; Mintun, Mark A; Sims, John R.
Afiliação
  • Shcherbinin S; Eli Lilly and Company Indianapolis Indiana USA.
  • Morris A; Eli Lilly and Company Indianapolis Indiana USA.
  • Higgins IA; Avid Radiopharmaceuticals Philadelphia Pennsylvania USA.
  • Tunali I; Eli Lilly and Company Indianapolis Indiana USA.
  • Lu M; Eli Lilly and Company Indianapolis Indiana USA.
  • Deveau C; Eli Lilly and Company Indianapolis Indiana USA.
  • Southekal S; Avid Radiopharmaceuticals Philadelphia Pennsylvania USA.
  • Kotari V; Eli Lilly and Company Indianapolis Indiana USA.
  • Evans CD; Eli Lilly and Company Indianapolis Indiana USA.
  • Arora AK; Avid Radiopharmaceuticals Philadelphia Pennsylvania USA.
  • Collins EC; Eli Lilly and Company Indianapolis Indiana USA.
  • Pontecorvo M; Avid Radiopharmaceuticals Philadelphia Pennsylvania USA.
  • Mintun MA; Eli Lilly and Company Indianapolis Indiana USA.
  • Sims JR; Eli Lilly and Company Indianapolis Indiana USA.
Alzheimers Dement (N Y) ; 9(3): e12415, 2023.
Article em En | MEDLINE | ID: mdl-37600216

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article